Skip to main content

Closed

MIST: Milestone Pharmaceuticals Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-3669.4%

ROIC-37.6%

Financially safe

Stretched

Debt / equity3.81×

Interest coverage-9.3×

Current ratio9.18×

Milestone Pharmaceuticals Inc.

MISTNASDAQ Global Select·USD·Closed

Milestone Pharmaceuticals Inc.

MISTNASDAQ·USD·Closed

$1.11

−3.48%

$1.11

−$0.04 (3.48%)

52W Range

5thpctl

Volume

0.75×avg

Mkt Cap

95.34MUSD

P/E

-1.7TTM

Div Yield

–ann

52W Range

5thpctl

Volume

0.75×avg

Market Cap

95.34MUSD

P/E Ratio

-1.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings